Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
Date:5/5/2009

, were $59.6 million, compared with $72.8 million at December 31, 2008. Management currently believes the existing cash and investment securities will provide adequate resources to fund the Company's operations into the first quarter of 2010.

Goals and Objectives

During the remainder of 2009 Poniard expects to:

  • Present progression-free survival data and safety data from two ongoing Phase 2 trials of picoplatin as first-line treatment for metastatic colorectal and castration-resistant prostate cancers (CRPC) at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO); the Company plans to hold an investor event featuring oncology experts at ASCO on Sunday, May 31;
  • Report top-line results from the pivotal Phase 3 SPEAR trial in SCLC in the second half 2009; and
  • Initiate submission of a New Drug Application with the U.S. Food and Drug Administration for picoplatin as a second-line treatment for SCLC, targeting approval and commercialization in 2010.

About Small Cell Lung Cancer

SCLC is the most aggressive form of lung cancer and tends to be widespread by the time of diagnosis. According to the American Cancer Society, in the U.S. in 2008 an estimated 32,000 new cases of SCLC were expected to be diagnosed and 52,000 SCLC patients were treated with therapy (American Cancer Society, Cancer Facts and Figures 2009). Patients with SCLC have few treatment options and a poor prognosis. Effective second-line treatment for SCLC is a major unmet medical need.

About Colorectal Cancer

CRC is the third most common cancer in both American men and women, and the third leading cause of cancer death in the U.S. In 2008, an estimated 148,810 new cases of colon and rectal cancer were expected to be diagnosed in the U.S., with an esti
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... , May 18, 2013 Faruqi & ... is investigating potential securities fraud at AVEO Pharmaceuticals, ... (Logo: http://photos.prnewswire.com/prnh/20120119/MM38856LOGO ) ... its executives violated federal securities laws by issuing ... Phase III drug trials for Tivopath (tivozanib) (titled ...
(Date:5/17/2013)... 2013  Sorrento Therapeutics, Inc. (OTCBB: SRNE; or ... Small Business Technology Transfer Research (STTR) grant (#1R42AI098182-02) ... Diseases (NIAID), a division of the National Institutes ... human antibody therapeutics to combat Staphylococcus aureus ... including methicillin-resistant S. aureus (MRSA), was ...
(Date:5/17/2013)... 2013  Sony Biotechnology Inc. ("Sony") today announced the launch ... 130um sorting chip.  Sony will also be exhibiting its newly ... Cell Sorter, the EC800 flow cytometer, and new SP6800 Spectral ... which will be held at the San Diego ... , from May 20 - 22.  ...
Breaking Medicine Technology:Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 2Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 3Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases 4Sony Delivers New Technology for Science to CYTO 2013 2
... Club (FC) Barcelona, FC Barcelona Foundation, and ... three-year partnership today to energize the global fight to ... life-saving vaccines.  Bill Gates, co-chair of the Bill & ... Rosell and Manager Josep Guardiola, announced the partnership at ...
... China, July 28, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: ... domestic developer, manufacturer and marketer of orthopedic implants in China, ... 2011 financial results on August 16, 2011, before the market ... 8:00 a.m. ET on August 16, 2011 to discuss second ...
Cached Medicine Technology:Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 2Futbol Club Barcelona and the Bill & Melinda Gates Foundation Team Up to End Polio and Give Every Child an Equal Shot at Life 3China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011 2
(Date:5/20/2013)... (PRWEB) May 20, 2013 FixturesAndDisplays.com, the ... comprehensive selection of high-quality retail clothing display options to ... and upscale retailers. Their expansive product line includes ... broad range of mannequin options. Recently ... its most popular models in reformulated “green” versions. ...
(Date:5/20/2013)... As a mother to three children, Lacy Arnold knows firsthand how ... fit, healthy lifestyle. She also knows the pains and frustrations associated ... of bricks about a year after giving birth to my first ... had lost control of my health and weighed over 200 pounds ... energy to care for my sweet little girl, and I was ...
(Date:5/20/2013)... 2013 Today is the last day ... Answers Webinar tomorrow. Job seekers cannot afford to ... career coach, will show job seekers what hiring managers ... also learn the perfect interview answers to the four ... that will get them hired. Job seekers will be ...
(Date:5/19/2013)... Alonso Krangle LLP, an experienced plaintiffs’ ... York woman in a Paternity Petition against Herschel ... (NFL). According to an April 23rd filing in New ... of paternity, order of support and further relief as may ... Walker. (Docket No. P-18821-13) , Herschel Walker, is a ...
(Date:5/19/2013)... 2013 The special introductory offer for ... end soon. "We are so excited to introduce our ... Sublime Beauty®. "It is a pleasure to use, it ... it also moisturizes the skin. One of the powerful ... that is very successful in clinical studies." , Collagen ...
Breaking Medicine News(10 mins):Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 2Health News:FixturesAndDisplays.com Offers Line of ‘Green’ Mannequins for Retail Displays 3Health News:New Program Helps Busy Moms Become Healthier, Lose Weight, and Feel Great 2Health News:Today Is the Last Day to Register for Tomorrow’s Perfect Interview Answers Webinar From Career Confidential 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 2Health News:New York Woman in Paternity Petition Against Former NFL Running Back, Herschel Walker, Alonso Krangle LLP Representing Petitioner 3
... 10, 2011 In 1980 in the United States, approximately ... By 2007 that figure had increased to 14%. Women over ... with trisomy 21. In a study published online today in ... researchers from the Sequenom Center for Molecular Medicine confirmed that ...
... like shots or needles, you,re in luck. New research published ... gives the development of new oral vaccinations a shot in ... mice. In addition, this research report also offers a tantalizing ... even if direct injections into the body fail to cause ...
... HealthDay Reporter , WEDNESDAY, Feb. 9 (HealthDay News) -- Surgery ... cord birth defect known as spina bifida may be most ... groundbreaking -- research suggests. When successful, the surgery could ... not, experts say, since twice as many spina bifida-affected children ...
... , THURSDAY, Feb. 10 (HealthDay News) -- Low ... associated with higher rates of obesity, researchers report. The ... in cities tend to be thinner because they have more ... have to drive most everywhere they go. For this ...
... FRANCISCO (February 10, 2011) In a study to ... (SMFM) annual meeting, The Pregnancy Meeting , in San ... rats, the use of magnesium sulfate (Mg) significantly reduced ... maternal infection. Magnesium sulfate is sometimes used during ...
... 10, 2011) In a study to be presented today ... Pregnancy Meeting , in San Francisco, researchers will present findings ... mothers in situations when labor has to be induced, that ... There are many reasons that labor may need to ...
Cached Medicine News:Health News:Noninvasive test for trisomy 21 closer at hand 2Health News:Salivary glands as organs of immunity: New research makes oral immunization easier to swallow 2Health News:Fetal Surgery Could Boost Outcomes in Severe Spina Bifida 2Health News:Fetal Surgery Could Boost Outcomes in Severe Spina Bifida 3Health News:Fetal Surgery Could Boost Outcomes in Severe Spina Bifida 4Health News:Study finds magnesium sulfate may offer protection from cerebral palsy 2Health News:When first-time mothers are induced, breaking the amniotic membrane shortens delivery time 2
Store microscope slides with ease, speed, efficiency....
... drawers for just about everything imaginable that might ... Each box is designed for long term storage ... of wood over metal systems is overlooked, while ... subtle kind of desiccator and insulator, providing an ...
A prepared Microscope Slide Cataloging and Storage System....
... resistant, plastic covered corrugated boxes interlock ... up to 500 lbs of overhead ... accommodates 2000 slides or 500 tissue ... requirements. Come unassembled boxes require minimal ...
Medicine Products: